WallStreetZenWallStreetZen

NYSE: PFE
Pfizer Inc Earnings & Revenue

PFE past earnings growth

How has PFE's earnings growth performed historically?
Company
-93.2%
Industry
0.36%
Market
104.46%
PFE's earnings have grown slower... subscribe to Premium to read more.
Earnings Growth vs Industry Performance
PFE's earnings have grown slower... subscribe to Premium to read more.
Earnings Growth vs Market Performance
PFE's earnings growth is slowing... subscribe to Premium to read more.
Accelerating Earnings Growth Performance

PFE past revenue growth

How has PFE's revenue growth performed historically?
Company
-41.7%
Industry
4.57%
Market
18.51%
PFE's revenue has grown faster... subscribe to Premium to read more.
Revenue Growth vs Industry Performance
PFE's revenue has grown slower... subscribe to Premium to read more.
Revenue Growth vs Market Performance
PFE's revenue growth is slowing... subscribe to Premium to read more.
Accelerating Revenue Growth Performance

PFE earnings and revenue history

Current Revenue
$58.5B
Current Earnings
$2.1B
Current Profit Margin
3.6%
PFE's has not demonstrated consistent... subscribe to Premium to read more.
Long-term Earnings Growth Trend Performance

PFE Return on Equity

Current Company
2.2%
Current Industry
34.2%
Current Market
188%
PFE's Return on Equity (2.2%)... subscribe to Premium to read more.
High Return on Equity Performance

Be the first to know when PFE announces earnings.

PFE Return on Assets

Current Company
1%
Current Industry
8.3%
PFE is generating lower Return... subscribe to Premium to read more.
Above Average Return on Assets Performance

PFE Return on Capital Employed

Current Company
0.56%
Current Industry
14.8%
PFE's ability to generate Return... subscribe to Premium to read more.
Increasing Return on Capital Employed Performance

PFE vs General Drug Manufacturer Stocks

TickerRevenueEBITDAEarningsY/Y RevenueY/Y Earnings
PFE$58.50B$7.29B$2.12B+7.46%-27.52%
AMGN$28.19B$14.80B$6.72B+3.49%-0.22%
SNY$49.94B$14.09B$5.81B+4.70%+3.84%
BMY$45.01B$18.19B$8.03B+14.81%+5.21%
AZN$45.81B$13.91B$5.96B+15.71%+17.70%

PFE earnings dates

Next earnings date
Apr 30, 2024

Pfizer Earnings & Revenue FAQ

What were PFE's earnings last quarter?

On Invalid Date, Pfizer (NYSE: PFE) reported Q4 2023 earnings per share (EPS) of -$0.59, up 167.05% year over year. Total Pfizer earnings for the quarter were -$3.37 billion. In the same quarter last year, Pfizer's earnings per share (EPS) was $0.88.

If you're new to stock investing, here's how to buy Pfizer stock.

What was PFE's earnings growth in the past year?

As of Q1 2024, Pfizer's earnings has grown -93.2% year over year. This is 93.56 percentage points lower than the US Drug Manufacturers - General industry earnings growth rate of 0.36%. Pfizer's earnings in the past year totalled $2.12 billion.

What is PFE's earnings date?

Pfizer's earnings date is Invalid Date. Add PFE to your watchlist to be reminded of PFE's next earnings announcement.

What was PFE's revenue last quarter?

On Invalid Date, Pfizer (NYSE: PFE) reported Q4 2023 revenue of $14.25 billion up 41.34% year over year. In the same quarter last year, Pfizer's revenue was $24.29 billion.

What was PFE's revenue growth in the past year?

As of Q1 2024, Pfizer's revenue has grown -41.7% year over year. This is 46.27 percentage points lower than the US Drug Manufacturers - General industry revenue growth rate of 4.57%. Pfizer's revenue in the past year totalled $58.50 billion.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.